Enriching diet with n-3 PUFAs to help prevent cardiovascular diseases in healthy adults: Results from clinical trials

International Journal of Molecular Sciences

Volumn 18, Issue 7, 2017, Pages

  Manuelli, Matteo ^a   Della Guardia, Lucio ^a   Cena, Hellas ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cardiovascular diseases; Omega 3 polyunsaturated fatty acids (n 3 PUFAs); Prevention

Indexed keywords

ALPHA TOCOPHEROL; CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PRIMROSE OIL; SOYBEAN OIL; SUNFLOWER OIL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; BLOOD PRESSURE; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; HEART FUNCTION; HEMP SEED; HUMAN; INFLAMMATION; LINSEED; NUTRITIONAL HEALTH; OXIDATIVE STRESS; PUBLICATION; REVIEW; SCIENTIFIC LITERATURE; THROMBOCYTE ACTIVATION; THROMBOSIS; CLINICAL TRIAL (TOPIC); DIET; DRUG EFFECT; PATHOPHYSIOLOGY;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIET; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 85025065791     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18071552     Document Type: Review

References (78)

1. Global Health Risks. Avaliale online: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf (accessed on 31 May 2007).
2. Galassi, A.; Reynolds, K.; He, J. Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am. J. Med. 2006, 119, 812–819. [CrossRef] [PubMed]
3. Jump, D.B.; Depner, C.M.; Tripathy, S. n-3 fatty acid supplementation and cardiovascular disease. J. Lipid Res. 2012, 53, 2525–2545. [CrossRef] [PubMed]
4. Reiner, Ž.; Catapano, A.L.; de Backer, G.; Graham, I.; Taskinen, M.R.; Wiklund, O.; Agewall, S.; Alegria, E.; Chapman, M.J.; Durrington, P.; et al. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur. Heart J. 2011, 32, 1769-1818.
5. Watanabe, Y.; Tatsuno, I. n-3 polyunsaturated fatty acids for cardiovascular diseases: Present, past and future. Exp. Rev. Clin. Pharmacol. 2017, 29, 1–9. [CrossRef] [PubMed]
6. Calder, P.C. The role of marine n-3 fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol. Nutr. Food Res. 2012, 56, 1073–1080. [CrossRef] [PubMed]
7. Tetens, I. Opinion of the Scientific Panel on Dietetic products, nutrition and allergies [NDA] related to nutrition claims concerning n-3 fatty acids, monounsaturated fat, polyunsaturated fat and unsaturated fat. EFSA 2005. [CrossRef]
8. DeFilippis, A.P.; Sperling, L.S. Understanding n-3’s. Am. Heart J. 2006, 151, 564–570. [CrossRef] [PubMed]
9. Dewailly, E.; Blanchet, C.; Lemieux, S.; Sauvé, L.; Gingras, S.; Ayotte, P.; Holub, B.J. n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am. J. Clin. Nutr. 2001, 74, 464–473. [PubMed]
10. Rizos, E.C.; Ntzani, E.E.; Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between n-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 2012, 308, 1024–1033. [CrossRef] [PubMed]
11. Maehre, H.K.; Jensen, I.J.; Elvevoll, E.O.; Eilertsen, K.E. ω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary Relevance. Int. J. Mol. Sci. 2015, 16, 22636–22661. [CrossRef] [PubMed]
12. Bowen, K.J.; Harris, W.S.; Kris-Etherton, P.M. n-3 Fatty Acids and Cardiovascular Disease: Are There Benefits? Curr. Treat. Options Cardiovasc. Med. 2016, 18, 69. [CrossRef] [PubMed]
13. Walz, C.P.; Barry, A.R.; Koshman, S.L. n-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease. Can. Pharm. J. 2016, 149, 166–173. [CrossRef] [PubMed]
14. Maurizi, G.; Della Guardia, L.; Maurizi, A.; Poloni, A. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. J. Cell Physiol. 2017. [CrossRef] [PubMed]
15. Endo, J.; Arita, M. Cardioprotective mechanism of n-3 polyunsaturated fatty acids. J. Cardiol. 2016, 67, 22–27. [CrossRef] [PubMed]
16. Antollini, S.S.; Barrantes, F.J. Fatty Acid Regulation of Voltage- and Ligand-Gated Ion Channel Function. Front. Physiol. 2016, 7, 573. [CrossRef] [PubMed]
17. Christou, G.A.; Christou, K.A.; Korantzopoulos, P.; Rizos, E.C.; Nikas, D.N.; Goudevenos, J.A. The Current Role of n-3 Fatty Acids in the Management of Atrial Fibrillation. Int. J. Mol. Sci. 2015, 16, 22870–22887. [CrossRef] [PubMed]
18. Calò, L.; Martino, A.; Tota, C. The anti-arrhythmic effects of n-3 PUFAs. Int. J. Cardiol. 2013, 170, S21–S27. [CrossRef] [PubMed]
19. Metcalf, R.G.; James, M.J.; Gibson, R.A.; Edwards, J.R.; Stubberfield, J.; Stuklis, R.; Roberts-Thomson, K.; Young, G.D.; Cleland, L.G. Effects of fish-oil supplementation on myocardial fatty acids in humans. Am. J. Clin. Nutr. 2007, 85, 1222–1228. [PubMed]
20. Liu, T.; Korantzopoulos, P.; Shehata, M.; Wang, X.; Kaul, S. Prevention of atrial fibrillation with n-3 fatty acids: A meta-analysis of randomised clinical trials. Heart 2011, 97, 1034–1040. [CrossRef] [PubMed]
21. Einvik, G.; Klemsdal, T.O.; Sandvik, L.; Hjerkinn, E.M. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur. J. Cardiovasc. Prev. Rehabil. 2010, 17, 588–592. [CrossRef] [PubMed]
22. Albert, C.M.; Hennekens, C.H.; O’Donnell, C.J.; Ajani, U.A.; Carey, V.J.; Willett, W.C.; Ruskin, J.N.; Manson, J.E. Fish consumption and risk of sudden cardiac death. JAMA 1998, 279, 23–28. [CrossRef] [PubMed]
23. Oomen, C.M.; Feskens, E.J.; Räsänen, L.; Fidanza, F.; Nissinen, A.M.; Menotti, A.; Kok, F.J.; Kromhout, D. Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands. Am. J. Epidemiol. 2000, 151, 999–1006. [CrossRef] [PubMed]
24. Mozaffarian, D.; Lemaitre, R.N.; Kuller, L.H.; Burke, G.L.; Tracy, R.P.; Siscovick, D.S. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: The Cardiovascular Health Study. Circulation 2003, 107, 1372–1377. [CrossRef] [PubMed]
25. Kris-Etherton, P.M.; Harris, W.S.; Appel, L.J. Fish consumption, fish oil, n-3 fatty acids, and cardiovascular disease. Circulation 2002, 106, 2747–2757. [CrossRef] [PubMed]
26. Wilkinson, P.; Leach, C.; Ah-Sing, E.E.; Hussain, N.; Miller, G.J.; Millward, D.J.; Griffin, B.A. Influence of alpha-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis 2005, 181, 115–124. [CrossRef] [PubMed]
27. Tholstrup, T.; Hellgren, L.I.; Petersen, M.; Basu, S.; Straarup, E.M.; Schnohr, P.; Sandström, B. A solid dietary fat containing fish oil redistributes lipoprotein subclasses without increasing oxidative stress in men. J. Nutr. 2004, 134, 1051–1057. [PubMed]
28. Hlais, S.; El-Bistami, D.; El Rahi, B.; Mattar, M.A.; Obeid, O.A. Combined fish oil and high oleic sunflower oil supplements neutralize their individual effects on the lipid profile of healthy men. Lipids 2013, 48, 853–861. [CrossRef] [PubMed]
29. Berge, R.K.; Ramsvik, M.S.; Bohov, P.; Svardal, A.; Nordrehaug, J.E.; Rostrup, E.; Bruheim, I.; Bjørndal, B. Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults—A pilot study. Lipids Health Dis. 2015, 14, 163. [CrossRef] [PubMed]
30. Miyoshi, T.; Yoko Noda, Y.; Yuko Ohno, Y.; Sugiyama, H.; Oe, H.; Nakamura, K.; Kohno, K.; Ito, H. n-3 fatty acids improve postprandial lipemia and associated endothelial dysfunction in healthy individuals—A randomized cross-over trial. Biomed. Pharmacother. 2014, 68, 1071–1077. [CrossRef] [PubMed]
31. Patel, P.; Abate, N. Role of subcutaneous adipose tissue in the pathogenesis of insulin resistance. J. Obes. 2013, 489187. [CrossRef] [PubMed]
32. Buckley, J.D.; Burgess, S.; Murphy, K.J.; Howe, P.R. DHA-rich fish oil lowers heart rate during submaximal exercise in elite Australian Rules footballers. J. Sci. Med. Sport 2009, 12, 503–507. [CrossRef] [PubMed]
33. Singhal, A.; Lanigan, J.; Storry, C.; Low, S.; Birbara, T.; Lucas, A.; Deanfield, J. Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: A randomized controlled trial in young adults. J. Am. Heart Assoc. 2013, 2, e000283. [CrossRef] [PubMed]
34. Stark, K.D.; Holub, B.J. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am. J. Clin. Nutr. 2004, 79, 765–773. [PubMed]
35. Cazzola, R.; Russo-Volpe, S.; Miles, E.A.; Rees, D.; Banerjee, T.; Roynette, C.E.; Wells, S.J.; Goua, M.; Wahle, K.W.; Calder, P.C.; et al. Age- and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects. Atherosclerosis 2007, 193, 159–167. [CrossRef] [PubMed]
36. Superko, H.R.; Pendyala, L.; Williams, P.T.; Momary, K.M.; King, S.B.; Garrett, B.C. High-density lipoprotein subclasses and their relationship to cardiovascular disease. J. Clin. Lipidol. 2012, 6, 496–523. [CrossRef] [PubMed]
37. Burillo, E.; Martín-Fuentes, P.; Mateo-Gallego, R.; Baila-Rueda, L.; Cenarro, A.; Ros, E.; Civeira, F. Omega-3 fatty acids and HDL. How do they work in the prevention of cardiovascular disease? Curr. Vasc. Pharmacol. 2012, 10, 432–441. [CrossRef] [PubMed]
38. Mensink, R.P.; Zock, P.L.; Kester, A.D.; Katan, M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003, 77, 1146–1155. [PubMed]
39. Wooten, J.S.; Biggerstaff, K.D.; Ben-Ezra, V. Responses of LDL and HDL particle size and distribution to omega-3 fatty acid supplementation and aerobic exercise. J. Appl. Physiol. 2009, 107, 794–800. [CrossRef] [PubMed]
40. Williams, P.T.; Krauss, R.M.; Vranizan, K.M.; Stefanick, M.L.; Wood, P.D.; Lindgren, F.T. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. Arterioscler. Thromb. 1992, 12, 332–340. [CrossRef] [PubMed]
41. Sioen, I.; Hacquebard, M.; Hick, G.; Maindiaux, V.; Larondelle, Y.; Carpentier, Y.A.; de Henauw, S. Effect of ALA-enriched food supply on cardiovascular risk factors in males. Lipids 2009, 44, 603–611. [CrossRef] [PubMed]
42. Nestel, P.J. Fish oil and cardiovascular disease: Lipids and arterial function. Am. J. Clin. Nutr. 2000, 71, 228S–231S. [PubMed]
43. Mori, T.A.; Burke, V.; Puddey, I.B.; Watts, G.F.; O’Neal, D.N.; Best, J.D.; Beilin, L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 2000, 71, 1085–1094. [PubMed]
44. Suzukawa, M.; Abbey, M.; Howe, P.R.; Nestel, P.J. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res. 1995, 36, 473–484. [PubMed]
45. Lamantia, V.; Sniderman, A.; Faraj, M. Nutritional management of hyperapoB. Nutr. Res. Rev. 2016, 29, 202–233. [CrossRef] [PubMed]
46. Kaul, N.; Kreml, R.; Austria, J.A.; Richard, M.N.; Edel, A.L.; Dibrov, E.; Hirono, S.; Zettler, M.E.; Pierce, G.N. A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J. Am. Coll. Nutr. 2008, 27, 51–58. [CrossRef] [PubMed]
47. Kirkhus, B.; Lamglait, A.; Eilertsen, K.E.; Falch, E.; Haider, T.; Vik, H.; Hoem, N.; Hagve, T.A.; Basu, S.; Olsen, E.; et al. Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects. Br. J. Nutr. 2012, 107, 1339–1349. [CrossRef] [PubMed]
48. Barceló-Coblijn, G.; Murphy, E.J.; Othman, R.; Moghadasian, M.H.; Kashour, T.; Friel, J.K. Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: A multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am. J. Clin. Nutr. 2008, 88, 801–809. [PubMed]
49. Grimsgaard, S.; Bønaa, K.H.; Hansen, J.B.; Myhre, E.S. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am. J. Clin. Nutr. 1998, 68, 52–59. [PubMed]
50. Shah, A.P.; Ichiuji, A.M.; Han, J.K.; Traina, M.; El-Bialy, A.; Kamal Meymandi, S.; Yvonne Wachsner, R. Cardiovascular and endothelial effects of fish oil supplementation in healthy volunteers. J. Cardiovasc. Pharmacol. Ther. 2007, 12, 213–219. [CrossRef] [PubMed]
51. Delodder, F.; Tappy, L.; Liaudet, L.; Schneiter, P.; Perrudet, C.; Berger, M.M. Incorporation and washout of n-3 PUFA after high dose intravenous and oral supplementation in healthy volunteers. Clin. Nutr. 2015, 34, 400–408. [CrossRef] [PubMed]
52. Holguin, F.; Téllez-Rojo, M.M.; Lazo, M.; Mannino, D.; Schwartz, J.; Hernández, M.; Romieu, I. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 2005, 127, 1102–1107. [CrossRef]
53. Geelen, A.; Zock, P.L.; Swenne, C.A.; Brouwer, I.A.; Schouten, E.G.; Katan, M.B. Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects. Am. Heart J. 2003, 146, E4. [CrossRef]
54. Nilsson, A.; Radeborg, K.; Salo, I.; Björck, I. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: A randomized controlled cross-over study. Nutr. J. 2012, 11, 99. [CrossRef] [PubMed]
55. Theobald, H.E.; Goodall, A.H.; Sattar, N.; Talbot, D.C.; Chowienczyk, P.J.; Sanders, T.A. Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J. Nutr. 2007, 137, 973–978. [PubMed]
56. Macartney, M.J.; Hingley, L.; Brown, M.A.; Peoples, G.E.; McLennan, P.L. Intrinsic heart rate recovery after dynamic exercise is improved with an increased n-3 index in healthy males. Br. J. Nutr. 2014, 112, 1984–1992. [CrossRef] [PubMed]
57. Phang, M.; Lincz, L.F.; Garg, M.L. Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women. J. Nutr. 2013, 143, 457–463. [CrossRef] [PubMed]
58. Conquer, J.A.; Cheryk, L.A.; Chan, E.; Gentry, P.A.; Holub, B.J. Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects. Thromb. Res. 1999, 96, 239–250. [CrossRef]
59. Leigh-Firbank, E.C.; Minihane, A.M.; Leake, D.S.; Wright, J.W.; Murphy, M.C.; Griffin, B.A.; Williams, C.M. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: Differential associations with lipid responses. Br. J. Nutr. 2002, 87, 435–445. [CrossRef] [PubMed]
60. Turini, M.E.; Crozier, G.L.; Donnet-Hughes, A.; Richelle, M.A. Short-term fish oil supplementation improved innate immunity, but increased ex vivo oxidation of LDL in man—A pilot study. Eur. J. Nutr. 2001, 40, 56–65. [CrossRef] [PubMed]
61. Mesa, M.D.; Buckley, R.; Minihane, A.M.; Yaqoob, P. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on the oxidizability and thrombogenicity of low-density lipoprotein. Atherosclerosis 2004, 175, 333–343. [CrossRef] [PubMed]
62. Miles, E.A.; Thies, F.; Wallace, F.A.; Powell, J.R.; Hurst, T.L.; Newsholme, E.A.; Calder, P.C. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin. Sci. 2001, 100, 91–100. [CrossRef] [PubMed]
63. De Caterina, R.; Basta, G.; Lazzerini, G.; Dell’Omo, G.; Petrucci, R.; Morale, M.; Carmassi, F.; Pedrinelli, R. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 2646–2654. [CrossRef] [PubMed]
64. Yang, Y.; Lu, N.; Chen, D.; Meng, L.; Zheng, Y.; Hui, R. Effects of n-3 PUFA supplementation on plasma soluble adhesion molecules: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2012, 95, 972–980. [CrossRef] [PubMed]
65. McEwen, B.J.; Morel-Kopp, M.C.; Tofler, G.H.; Ward, C.M. The effect of n-3 polyunsaturated fatty acids on fibrin and thrombin generation in healthy subjects and subjects with cardiovascular disease. Semin. Thromb. Hemost. 2015, 41, 315–322. [CrossRef] [PubMed]
66. Guillot, N.; Caillet, E.; Laville, M.; Calzada, C.; Lagarde, M.; Véricel, E. Increasing intakes of the long-chain omega-3 docosahexaenoic acid: Effects on platelet functions and redox status in healthy men. FASEB J. 2009, 23, 2909–2916. [CrossRef] [PubMed]
67. Colussi, G.; Catena, C.; Novello, M.; Bertin, N.; Sechi, L.A. Impact of n-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes. Nutr. Metab. Cardiovasc. Dis. 2017, 27, 191–200. [CrossRef] [PubMed]
68. Khan, F.; Elherik, K.; Bolton-Smith, C.; Barr, R.; Hill, A.; Murrie, I.; Belch, J.J. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovasc. Res. 2003, 59, 955–962. [CrossRef]
69. Fahs, C.A.; Yan, H.; Ranadive, S.; Rossow, L.M.; Agiovlasitis, S.; Wilund, K.R.; Fernhall, B. The effect of acute fish-oil supplementation on endothelial function and arterial stiffness following a high-fat meal. Appl. Physiol. Nutr. Metab. 2010, 35, 294–302. [CrossRef] [PubMed]
70. Fisher, E.; Lake, E.; McLeod, R.S. Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion. J. Biomed. Res. 2014, 28, 178–193. [PubMed]
71. Flock, M.R.; Skulas-Ray, A.C.; Harris, W.S.; Gaugler, T.L.; Fleming, J.A.; Kris-Etherton, P.M. Effects of supplemental long-chain n-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults. Prostaglandins Leukot. Essent. Fatty Acids 2014, 91, 161–168. [CrossRef] [PubMed]
72. Falsey, A.R.; Walsh, E.E.; Francis, C.W.; Looney, R.J.; Kolassa, J.E.; Hall, W.J.; Abraham, G.N. Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. J. Infect. Dis. 2001, 183, 995–999. [CrossRef] [PubMed]
73. Kasapis, C.; Thompson, P.D. The effects of physical activity on serum C-reactive protein and inflammatory markers: A systematic review. J. Am. Coll. Cardiol. 2005, 45, 1563–1569. [CrossRef] [PubMed]
74. Steptoe, A.; Hamer, M.; Chida, Y. The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain Behav. Immun. 2007, 21, 901–912. [CrossRef] [PubMed]
75. Omega-3 Supplements: In Depth. Available online: https://nccih.nih.gov/health/omega3/introduction.htm (accessed on 31 May 2007).
76. Decsi, T.; Kennedy, K. Sex-specific differences in essential fatty acid metabolism. Am. J. Clin. Nutr. 2011, 94, 1914S–1919S. [CrossRef] [PubMed]
77. Flynn, M.A. Empowering people to be healthier: Public health nutrition through the Ottawa Charter. Proc. Nutr. Soc. 2015, 74, 303–312. [CrossRef] [PubMed]
78. Craig, W.J.; Mangels, A.R.; American Dietetic Association. Position of the American Dietetic Association: Vegetarian diets. J. Am. Diet. Assoc. 2009, 109, 1266–1282. [PubMed]